SCHEMBL7964271

SCHEMBL7964271

CC(C)c1cc(/C=C(/C#N)S(=O)(=O)Cc2cccc(C(F)(F)F)c2)cc(C(C)C)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.42
▸ KDR P35968 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ EGFR P00533 1/20 0.41
▸ LMNA P02545 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ HTR2B P41595 2/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ EPHX1 P07099 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ GALR3 O60755 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ AKR1B1 P15121 1/20 0.35
▸ ACP3 P15309 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964275 1.00 MAPT (0.42) MAPTKDRSMN1; SMN2EGFRLMNA
SCHEMBL7964269 1.00 MAPT (0.42) MAPTKDRSMN1; SMN2EGFRLMNA
SCHEMBL7963389 0.87 LMNA (0.38) MAPTEGFRLMNAGAAHTR2A
SCHEMBL7963384 0.87 LMNA (0.38) MAPTEGFRLMNAGAAHTR2A
SCHEMBL7963391 0.87 LMNA (0.38) MAPTEGFRLMNAGAAHTR2A
SCHEMBL7964110 0.85 MAPT (0.43) MAPTSMN1; SMN2EGFRLMNAGAA
SCHEMBL7964107 0.85 MAPT (0.43) MAPTSMN1; SMN2EGFRLMNAGAA
SCHEMBL7964113 0.85 MAPT (0.43) MAPTSMN1; SMN2EGFRLMNAGAA
SCHEMBL7967179 0.82 SMN1; SMN2 (0.44) MAPTKDRSMN1; SMN2EGFRLMNA
SCHEMBL7967176 0.82 SMN1; SMN2 (0.44) MAPTKDRSMN1; SMN2EGFRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 — — WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 — — US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 — — US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US disclosed
Send feedback